Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
about
MSMB variation and prostate cancer risk: clues towards a possible fungal etiologyDesign and analysis issues in gene and environment studiesComparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsCharacterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levelsProstate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levelsDPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialGenetic correction of PSA values using sequence variants associated with PSA levels.Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Estimation of absolute risk for prostate cancer using genetic markers and family history.Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.Early detection of prostate cancer with emphasis on genetic markers.Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?Frequency of KLK3 gene deletions in the general population.Meta-analysis of association between rs1447295 polymorphism and prostate cancer susceptibility.Personalized prostate cancer screening: improving PSA tests with genomic information.A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population
P2860
Q27025389-3B413C76-4059-4AD6-94C5-66A7028B5161Q29109926-2BDA008A-8A56-4B19-8C36-C7B75E6BFD8AQ33780848-56AD64D9-2D07-41D6-A418-380D1A187CC2Q33782243-956E9DCB-97DE-4CA3-923B-266535345158Q33842251-0318F439-0179-429D-ADAE-E3C0EA941416Q34158465-77CF01BD-31A8-447C-A2F0-8DA097AFE24CQ34688123-2C2F0BC2-A044-4E8B-9CE5-FADC170C38A8Q34964029-E4572ED9-3448-4B0C-AAC9-E928449009FEQ35020463-51ED2A44-0CD9-4205-B990-7F7BE2262E2AQ35135067-3E24A743-009C-4E5F-B640-68A0C9F74BABQ35796865-3F6485AB-C02B-4D69-901F-B35F7F15C5C1Q35863853-B7C71B56-F06C-4590-9ADF-344FCF3D7F47Q35952102-8DC9AFBD-FAA9-4ACA-AAEE-4D33FC3DB85DQ36588082-6ED0B696-DCA7-4966-ABC4-9409C164A502Q36827156-17E556D5-D98A-4780-AF9B-E7E60FBF68C9Q37122541-0F858CDD-6F8D-4C2E-BF8E-30BA4328C4C2Q37475917-F65E2388-DD84-47CE-B165-1A978544B54EQ37573519-49D3226E-DB1B-4178-BF46-87731A604CF5Q37622580-A65C6F75-A29A-4503-AC3F-2ACB63974D3AQ37878464-492151EC-AACF-4EE2-A455-A87568613243Q39852672-F730C737-2F22-4FFB-820E-89482E2C928CQ40609702-13F79D8A-7B9C-4EC1-B656-B42F8FD83936Q42366525-9AC03CEB-0C0C-4635-A740-6C90146F2ECCQ45978317-8A7C0449-875C-44E2-9DBD-FD8A183937E0Q57918012-02DE132D-5E3A-4CE9-8439-374720088EF3
P2860
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Association of reported prosta ...... diagnosis of prostate cancer.
@ast
Association of reported prosta ...... diagnosis of prostate cancer.
@en
type
label
Association of reported prosta ...... diagnosis of prostate cancer.
@ast
Association of reported prosta ...... diagnosis of prostate cancer.
@en
prefLabel
Association of reported prosta ...... diagnosis of prostate cancer.
@ast
Association of reported prosta ...... diagnosis of prostate cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Association of reported prosta ...... diagnosis of prostate cancer.
@en
P2093
Bao-Li Chang
David Duggan
Fang-Chi Hsu
Fredrik Wiklund
Jielin Sun
John D Carpten
Pär Stattin
S Lilly Zheng
Scott D Cramer
William B Isaacs
P2860
P304
P356
10.1002/PROS.20908
P577
2009-03-01T00:00:00Z